We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BMS Announces Fails Phase 3 Trial

News   Aug 08, 2016

 
BMS Announces Fails Phase 3 Trial
 
 
 

RELATED ARTICLES

Male Birth Control Pill Passes Human Safety Tests

News

A new male birth control pill passed tests of safety and tolerability when healthy men used it daily for a month, and it produced hormone responses consistent with effective contraception, according to researchers at two institutions testing the drug.

READ MORE

Twin Registry Used to Reveal Autoimmune Drivers

News

Data from the world’s largest twin registry shows that the risk of developing seven autoimmune diseases is largely inherited, but that some diseases are more closely related than others.

READ MORE

Drug Designed to Treat Opioid Cravings Begins Clinical Trial Testing

News

Researchers at the University of Maryland School of Medicine (UMSOM) Institute of Human Virology (IHV) are collaborating with scientists at the National Institutes of Health to test an experimental drug to curb opioid cravings.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE